These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 30810479

  • 21. Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.
    Cines DB, Gernsheimer T, Wasser J, Godeau B, Provan D, Lyons R, Altomare I, Wang X, Lopez A.
    Int J Hematol; 2015 Sep; 102(3):259-70. PubMed ID: 26201709
    [Abstract] [Full Text] [Related]

  • 22. Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.
    Grainger JD, Kühne T, Hippenmeyer J, Cooper N.
    Ann Hematol; 2021 Sep; 100(9):2143-2154. PubMed ID: 34308495
    [Abstract] [Full Text] [Related]

  • 23. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura.
    Zhang Y, Kolesar JM.
    Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810
    [Abstract] [Full Text] [Related]

  • 24. Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.
    Zhang J, Liang Y, Ai Y, Li X, Xie J, Li Y, Zheng W, He R.
    PLoS One; 2018 Nov; 13(6):e0198504. PubMed ID: 29856837
    [Abstract] [Full Text] [Related]

  • 25. Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists.
    Rottenstreich A, Bussel JB.
    Br J Haematol; 2023 Dec; 203(5):872-885. PubMed ID: 37830251
    [Abstract] [Full Text] [Related]

  • 26. A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia.
    Grainger JD, Thind S.
    Pediatr Hematol Oncol; 2017 Mar; 34(2):73-89. PubMed ID: 28537785
    [Abstract] [Full Text] [Related]

  • 27. Current Management of Primary Immune Thrombocytopenia.
    Provan D, Newland AC.
    Adv Ther; 2015 Oct; 32(10):875-87. PubMed ID: 26499177
    [Abstract] [Full Text] [Related]

  • 28. Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
    González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ.
    Br J Haematol; 2015 Apr; 169(1):111-6. PubMed ID: 25521630
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults.
    Červinek L, Mayer J, Doubek M.
    Int J Hematol; 2015 Jul; 102(1):7-11. PubMed ID: 25833724
    [Abstract] [Full Text] [Related]

  • 31. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.
    Rodeghiero F, Carli G.
    Ann Hematol; 2017 Sep; 96(9):1421-1434. PubMed ID: 28275823
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T, Imbach P.
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.